Patent ID: 9597384
Date: 2017-03-21
CPC Classifications: A61K,A61P

Claim:
1. A method of treating a tumor disease in a patient comprising administering to said patient a therapeutically effective amount of semi-allogeneic HLA-haploidentical antigen presenting cells (APCs) into which proteins and/or peptides or RNA, DNA, or cDNA encoding said proteins and/or peptides have been introduced, wherein said proteins and/or peptides are tumor-defined antigens, wherein said semi-allogeneic HLA-haploidentical APCs have class I and class II molecules in common with the patient, and wherein the tumor disease is selected from the group consisting of a carcinoma, a tumor of the hematopoietic system, a mesenchymal tumor, an epithelial tumor, an ectodermal tumor, and an embryonic tumor from undifferentiated tissue.